Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/28/2023 | 35.85% | Needham | $34 → $23 | Maintains | Buy |
05/11/2023 | 53.57% | Wedbush | $32 → $26 | Maintains | Neutral |
05/10/2023 | 148.08% | Needham | → $42 | Reiterates | → Buy |
03/03/2023 | 148.08% | Needham | → $42 | Reiterates | → Buy |
02/10/2023 | 89.01% | Wedbush | $25 → $32 | Maintains | Neutral |
02/09/2023 | 83.11% | Goldman Sachs | $19 → $31 | Maintains | Neutral |
02/09/2023 | 136.27% | Craig-Hallum | → $40 | Upgrades | Hold → Buy |
02/09/2023 | 77.2% | Baird | $23 → $30 | Maintains | Neutral |
02/09/2023 | 89.01% | Wells Fargo | $25 → $32 | Maintains | Overweight |
02/09/2023 | 148.08% | Needham | $40 → $42 | Maintains | Buy |
11/30/2022 | 12.23% | Goldman Sachs | $17 → $19 | Maintains | Neutral |
11/30/2022 | 136.27% | Needham | $30 → $40 | Maintains | Buy |
11/15/2022 | 47.67% | Wells Fargo | $48 → $25 | Maintains | Overweight |
10/11/2022 | 0.41% | Goldman Sachs | $30 → $17 | Maintains | Neutral |
08/10/2022 | 77.2% | Goldman Sachs | $34 → $30 | Maintains | Neutral |
08/10/2022 | 29.95% | RBC Capital | $27 → $22 | Maintains | Sector Perform |
08/10/2022 | — | Craig-Hallum | Downgrades | Buy → Hold | |
08/10/2022 | 183.52% | Wells Fargo | $64 → $48 | Maintains | Overweight |
08/10/2022 | — | Raymond James | Downgrades | Outperform → Market Perform | |
08/10/2022 | 77.2% | Needham | $46 → $30 | Maintains | Buy |
07/11/2022 | 278.03% | Wells Fargo | $66 → $64 | Maintains | Overweight |
07/07/2022 | 59.48% | RBC Capital | $28 → $27 | Upgrades | Underperform → Sector Perform |
05/12/2022 | 100.83% | Goldman Sachs | $44 → $34 | Maintains | Neutral |
05/11/2022 | 289.84% | Wells Fargo | $67 → $66 | Maintains | Overweight |
05/11/2022 | 65.39% | RBC Capital | $34 → $28 | Maintains | Underperform |
05/11/2022 | 171.71% | Needham | $78 → $46 | Maintains | Buy |
04/01/2022 | 295.75% | Wells Fargo | $68 → $67 | Maintains | Overweight |
02/22/2022 | 159.89% | Goldman Sachs | → $44 | Downgrades | Buy → Neutral |
02/14/2022 | 224.87% | Evercore ISI Group | → $55 | Downgrades | Outperform → In-Line |
02/09/2022 | 360.72% | Needham | $165 → $78 | Maintains | Buy |
02/08/2022 | 165.8% | Wedbush | $115 → $45 | Downgrades | Outperform → Neutral |
02/08/2022 | 136.27% | Jefferies | → $40 | Downgrades | Buy → Hold |
02/08/2022 | 195.33% | Baird | → $50 | Downgrades | Outperform → Neutral |
02/08/2022 | 118.55% | RBC Capital | → $37 | Downgrades | Sector Perform → Underperform |
02/08/2022 | 348.91% | Raymond James | $100 → $76 | Maintains | Outperform |
01/14/2022 | 354.81% | RBC Capital | $95 → $77 | Downgrades | Outperform → Sector Perform |
01/10/2022 | 508.39% | Goldman Sachs | $115 → $103 | Maintains | Buy |
12/16/2021 | 402.07% | Wells Fargo | → $85 | Upgrades | Equal-Weight → Overweight |
12/07/2021 | 490.67% | Raymond James | → $100 | Upgrades | Market Perform → Outperform |
11/23/2021 | 579.27% | Wedbush | $140 → $115 | Maintains | Outperform |
11/23/2021 | 579.27% | Goldman Sachs | $134 → $115 | Maintains | Buy |
11/23/2021 | 437.51% | Wells Fargo | $95 → $91 | Maintains | Equal-Weight |
11/23/2021 | 461.13% | RBC Capital | $110 → $95 | Maintains | Outperform |
10/06/2021 | 549.73% | RBC Capital | → $110 | Upgrades | Sector Perform → Outperform |
10/05/2021 | 461.13% | Wells Fargo | $113 → $95 | Maintains | Equal-Weight |
09/10/2021 | 567.45% | Wells Fargo | $115 → $113 | Maintains | Equal-Weight |
08/16/2021 | 786% | Evercore ISI Group | $125 → $150 | Maintains | Outperform |
08/10/2021 | 697.4% | Baird | $122 → $135 | Maintains | Outperform |
08/10/2021 | 579.27% | Wells Fargo | $108 → $115 | Maintains | Equal-Weight |
08/10/2021 | 756.47% | Craig-Hallum | $135 → $145 | Maintains | Buy |
08/10/2021 | 573.36% | RBC Capital | $105 → $114 | Maintains | Sector Perform |
08/10/2021 | 874.6% | Needham | $155 → $165 | Maintains | Buy |
07/07/2021 | — | Raymond James | Downgrades | Outperform → Market Perform | |
06/04/2021 | 620.61% | Baird | → $122 | Initiates Coverage On | → Outperform |
05/18/2021 | 638.33% | Evercore ISI Group | → $125 | Upgrades | In-Line → Outperform |
05/11/2021 | 667.87% | Wedbush | $150 → $130 | Maintains | Outperform |
03/26/2021 | 490.67% | Wells Fargo | → $100 | Initiates Coverage On | → Equal-Weight |
03/11/2021 | 591.08% | Berenberg | → $117 | Upgrades | Hold → Buy |
02/19/2021 | 815.53% | Needham | $125 → $155 | Maintains | Buy |
02/10/2021 | 667.87% | Raymond James | $80 → $130 | Maintains | Outperform |
02/09/2021 | 697.4% | Craig-Hallum | $90 → $135 | Maintains | Buy |
02/09/2021 | 520.2% | RBC Capital | $88 → $105 | Maintains | Sector Perform |
02/09/2021 | 786% | Wedbush | $120 → $150 | Maintains | Outperform |
02/09/2021 | 638.33% | Needham | $120 → $125 | Maintains | Buy |
01/15/2021 | 608.8% | Needham | $95 → $120 | Maintains | Buy |
01/08/2021 | 520.2% | Evercore ISI Group | → $105 | Downgrades | Outperform → In-Line |
12/10/2020 | 449.32% | Berenberg | → $93 | Initiates Coverage On | → Hold |
11/17/2020 | 461.13% | Needham | $82 → $95 | Maintains | Buy |
11/17/2020 | 431.6% | Wedbush | $75 → $90 | Maintains | Outperform |
11/17/2020 | 325.28% | RBC Capital | → $72 | Downgrades | Outperform → Sector Perform |
11/17/2020 | 372.53% | Raymond James | $56 → $80 | Maintains | Outperform |
10/23/2020 | 343% | Wedbush | $60 → $75 | Maintains | Outperform |
10/16/2020 | 384.35% | Needham | → $82 | Initiates Coverage On | → Buy |
08/05/2020 | 230.77% | Raymond James | $40 → $56 | Maintains | Outperform |
07/01/2020 | 195.33% | RBC Capital | → $50 | Initiates Coverage On | → Outperform |
06/08/2020 | 177.61% | Jefferies | → $47 | Initiates Coverage On | → Buy |
06/01/2020 | 130.36% | Cowen & Co. | $28 → $39 | Maintains | Outperform |
05/27/2020 | 136.27% | Wedbush | $27 → $40 | Maintains | Outperform |
05/26/2020 | — | Raymond James | Downgrades | Strong Buy → Outperform | |
05/12/2020 | 65.39% | Cowen & Co. | → $28 | Initiates Coverage On | → Outperform |
01/07/2020 | 0.41% | Goldman Sachs | → $17 | Initiates Coverage On | → Sell |
What is the target price for Cerence (CRNC)?
The latest price target for Cerence (NASDAQ: CRNC) was reported by Needham on November 28, 2023. The analyst firm set a price target for $23.00 expecting CRNC to rise to within 12 months (a possible 35.85% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cerence (CRNC)?
The latest analyst rating for Cerence (NASDAQ: CRNC) was provided by Needham, and Cerence maintained their buy rating.
When is the next analyst rating going to be posted or updated for Cerence (CRNC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cerence, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cerence was filed on November 28, 2023 so you should expect the next rating to be made available sometime around November 28, 2024.
Is the Analyst Rating Cerence (CRNC) correct?
While ratings are subjective and will change, the latest Cerence (CRNC) rating was a maintained with a price target of $34.00 to $23.00. The current price Cerence (CRNC) is trading at is $16.93, which is out of the analyst's predicted range.